Image via Cloud DX
(Source: Cloud DX.)
  • Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000
  • The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture
  • The debentures will bear 18 per cent interest per annum
  • Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care
  • Cloud DX Inc. (CDX) opened trading at C$0.155

Cloud DX (CDX) has announced plans to launch a non-brokered private placement for aggregate gross proceeds of up to $1,750,000.

The company will issue up to 1,750 secured convertible debentures at a price of $1,000 per debenture.

The debentures will mature 12 months after they’re issued and shall bear 18 per cent interest per annum. The principal amount of the debenture is convertible into common shares at a conversion price of $0.15 per share any time prior to the maturity date.

Net proceeds will be used for inventory and general working capital purposes.

The offering is expected to occur in one or more tranches, with the first tranche scheduled to close on or about June 24, 2022.

The debentures and any securities issued upon conversion will be subject to a statutory four-month hold period. The offering is subject to TSX Venture Exchange approval.

Cloud DX provides a digital and virtual health care platform for patient remote monitoring and hospital-quality post-surgical care.

Cloud DX Inc. (CDX) opened trading at C$0.155.

More From The Market Online

Canadian quantum computing company signs industrial-scale deal

Canadian quantum computing company Xanadu partners with EV Group to accelerate the scaling of photonic quantum systems.

The nature of oil shocks and how to invest to avoid them

In this article, we'll discuss the nature of oil shocks, pinpointing how to invest to foster a more sustainable energy supply chain.

Cannabix delivers marijuana breath test to Eastern Canada workplace testing clinic

Cannabix Technologies (CSE:BLO) delivered its Marijuana Breath Test devices to a workplace drug and alcohol testing clinic in eastern Canada.

Loblaw taps Canadian company to scale AI operations

Grocery giant Loblaw (TSX:L) partners with Shakudo, a Canadian technology firm, to better align itself with the benefits of AI.